ECSP15011603A - Subunidades de vacunas de inmersión para peces - Google Patents

Subunidades de vacunas de inmersión para peces

Info

Publication number
ECSP15011603A
ECSP15011603A ECIEPI201511603A ECPI201511603A ECSP15011603A EC SP15011603 A ECSP15011603 A EC SP15011603A EC IEPI201511603 A ECIEPI201511603 A EC IEPI201511603A EC PI201511603 A ECPI201511603 A EC PI201511603A EC SP15011603 A ECSP15011603 A EC SP15011603A
Authority
EC
Ecuador
Prior art keywords
subunities
immersion vaccine
fish
fish immersion
vaccine
Prior art date
Application number
ECIEPI201511603A
Other languages
English (en)
Inventor
Norman William Johnson
Joseph Michale Bricker
Elizabeth Mary Crump
William Wayne Kay
Jan Burian
Original Assignee
Proteos Biotech S L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Proteos Biotech S L filed Critical Proteos Biotech S L
Publication of ECSP15011603A publication Critical patent/ECSP15011603A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/0216Bacteriodetes, e.g. Bacteroides, Ornithobacter, Porphyromonas
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/0208Specific bacteria not otherwise provided for
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/54Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/55Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552Veterinary vaccine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/70Multivalent vaccine
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011Details
    • C12N2720/10011Birnaviridae
    • C12N2720/10034Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A40/00Adaptation technologies in agriculture, forestry, livestock or agroalimentary production
    • Y02A40/80Adaptation technologies in agriculture, forestry, livestock or agroalimentary production in fisheries management
    • Y02A40/81Aquaculture, e.g. of fish

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)

Abstract

La presente divulgación proporciona una vacuna de inmersión para peces que comprende al menos un antígeno aislado, específicamente un antígeno recombinante, tal como F. psychrophilum y o el virus de la necrosis pancreática infecciosa (VNPI).
ECIEPI201511603A 2012-09-26 2015-03-25 Subunidades de vacunas de inmersión para peces ECSP15011603A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201261705704P 2012-09-26 2012-09-26

Publications (1)

Publication Number Publication Date
ECSP15011603A true ECSP15011603A (es) 2015-12-31

Family

ID=49354907

Family Applications (1)

Application Number Title Priority Date Filing Date
ECIEPI201511603A ECSP15011603A (es) 2012-09-26 2015-03-25 Subunidades de vacunas de inmersión para peces

Country Status (13)

Country Link
US (2) US9623099B2 (es)
EP (1) EP2900258B8 (es)
CN (1) CN104884084B (es)
CA (1) CA2885333C (es)
CL (2) CL2015000771A1 (es)
CR (1) CR20150170A (es)
EC (1) ECSP15011603A (es)
ES (1) ES2792124T3 (es)
HK (1) HK1213478A1 (es)
MX (1) MX2015003825A (es)
PH (2) PH12015500612B1 (es)
SA (1) SA515360198B1 (es)
WO (1) WO2014052378A2 (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104884084B (zh) * 2012-09-26 2018-05-22 Fvg有限公司 鱼用亚单位浸泡疫苗
JP6045895B2 (ja) 2012-10-01 2016-12-14 株式会社トプコン 眼科観察装置
EP4241853B1 (en) * 2013-11-26 2026-02-11 Zoetis Services LLC Compositions for induction of immune response
CA2954876A1 (en) * 2014-07-11 2016-01-14 Fundacion Fraunhofer Chile Research Agent with antiviral properties for preventing or treating individuals exposed to a virus of the birnaviridae family
CR20210528A (es) 2014-12-15 2021-12-06 Univ Columbia VIRUS NUEVO DE TILAPIA Y USOS DEL MISMO(Divisional Exp: 2017-0322)
US10640752B2 (en) 2014-12-22 2020-05-05 Veterinærinstituttet Salmon gill poxvirus
CN104560851B (zh) * 2014-12-29 2019-03-26 江苏海健前沿生物科技有限公司 杀鲑气单胞菌活疫苗制剂和冻干疫苗制品的制备方法及应用
US10251970B1 (en) 2014-12-30 2019-04-09 Zee Company Air sanitation apparatus for food processing tanks having air agitation piping and methods thereof
US20180325970A1 (en) * 2016-07-29 2018-11-15 Saponin Research Center S.A. Use of quillaja saponaria extracts for the prevention and control of bacterial infections in fish
WO2018018171A1 (es) 2016-07-29 2018-02-01 Saponin Research Center S.A. Uso de extractos de quillaja saponaria para la prevención y control de infecciones virales en peces
KR101958169B1 (ko) * 2017-04-03 2019-03-20 대한민국 Vhsv 백신 및 아쥬반트를 함유하는 백신 조성물
US20210368745A1 (en) * 2017-12-21 2021-12-02 Gis Gas Infusion Systems Inc. Method and apparatus for fish farms
CN109136200B (zh) * 2018-09-20 2022-02-18 中国水产科学研究院黑龙江水产研究所 一种重组传染性造血器官坏死病毒及其构建方法与应用
CA3130159A1 (en) 2019-02-15 2020-08-20 Abera Bioscience Ab Decorated inclusion body and uses thereof
CN113080114A (zh) * 2021-04-12 2021-07-09 浙江大学 一种提高鱼类子代成活率的方法
CN113521265B (zh) * 2021-09-13 2021-11-23 深圳万可森生物科技有限公司 一种鲈鱼弹状病毒亚单位疫苗及其制备方法
CN115804837B (zh) * 2022-02-24 2023-06-20 中国水产科学研究院黑龙江水产研究所 一种传染性胰脏坏死病佐剂疫苗及其制备方法
CN115715800B (zh) * 2022-11-25 2025-10-28 南方海洋科学与工程广东省实验室(广州) 一种嗜水气单胞菌的亚单位纳米疫苗及其制备方法和应用
CN116077638B (zh) * 2022-12-20 2024-03-26 国药中生生物技术研究院有限公司 一种复合佐剂
CN118743751B (zh) * 2024-06-28 2025-02-25 广州南沙华农渔业研究院 一种鱼类柱形病亚单位疫苗及其应用

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4009259A (en) 1975-10-03 1977-02-22 Wildlife Vaccines, Inc. Immersion method for treating aquatic animals
US4287179A (en) 1978-08-31 1981-09-01 Tavolek Inc. Immersion vaccine for enteric redmouth
US4282828A (en) 1980-03-10 1981-08-11 Tavolek, Inc. Shower vaccination apparatus
US4363290A (en) 1981-06-26 1982-12-14 Wildlife Vaccines, Inc. Method and apparatus for automated immersion treatment of fish
US5703055A (en) 1989-03-21 1997-12-30 Wisconsin Alumni Research Foundation Generation of antibodies through lipid mediated DNA delivery
US6699907B1 (en) 1996-02-20 2004-03-02 Westfaliasurge, Inc. Fatty acid antimicrobial
US6673374B2 (en) 1998-07-31 2004-01-06 Howard Murad Pharmaceutical compositions and methods for managing skin conditions
US20040086524A1 (en) * 1999-09-17 2004-05-06 Kuzyk Michael A. Vaccines and agents for inducing immunity in fish against rickettsial diseases, and associated preventative therapy
US6518252B2 (en) 2000-09-20 2003-02-11 University Of Georgia Research Foundation, Inc. Method of treating aquatic animals with an antimicrobial agent and chelating agent
CA2428027C (en) 2000-11-11 2012-09-11 The University Court Of The University Of Aberdeen Yeast derived vaccine against ipnv
WO2002074173A1 (en) 2001-03-16 2002-09-26 Alza Corporation Method and apparatus for coating skin piercing microprojections
DE10123327C1 (de) * 2001-05-12 2002-11-28 Koenig & Bauer Ag Zwischenspeichervorrichtung für Stapel von Druckerzeugnissen
WO2003013597A1 (en) * 2001-08-10 2003-02-20 University Of Maryland Biotechnology Institute Sub-unit vaccine for infectious pancreatic necrosis virus
US6872386B2 (en) 2001-09-05 2005-03-29 Academia Sinica Oral vaccines
US6893667B2 (en) 2002-03-22 2005-05-17 Council Of Scientific And Industrial Research Protein profiling of hyper acidic plants and high protein extraction compositions thereof
CA2583113C (en) 2004-10-05 2015-11-10 Diversa Corporation Compositions comprising an antigen and a promiscuous t-cell epitope
US7740864B2 (en) 2007-06-22 2010-06-22 University Of Idaho Vaccines for diseases of fish
CN104884084B (zh) * 2012-09-26 2018-05-22 Fvg有限公司 鱼用亚单位浸泡疫苗

Also Published As

Publication number Publication date
US20150343043A1 (en) 2015-12-03
EP2900258A2 (en) 2015-08-05
WO2014052378A3 (en) 2014-10-02
US20170348406A1 (en) 2017-12-07
EP2900258B8 (en) 2020-04-01
HK1213478A1 (zh) 2016-07-08
WO2014052378A2 (en) 2014-04-03
CL2015000771A1 (es) 2016-07-01
CN104884084A (zh) 2015-09-02
PH12018501602A1 (en) 2019-04-01
MX2015003825A (es) 2015-11-06
PH12015500612A1 (en) 2015-05-11
CA2885333C (en) 2021-02-09
PH12015500612B1 (en) 2015-05-11
US10653763B2 (en) 2020-05-19
CA2885333A1 (en) 2014-04-03
CR20150170A (es) 2015-06-24
CN104884084B (zh) 2018-05-22
SA515360198B1 (ar) 2016-12-12
WO2014052378A8 (en) 2014-08-07
CL2018002394A1 (es) 2019-06-21
EP2900258B1 (en) 2020-02-19
US9623099B2 (en) 2017-04-18
ES2792124T3 (es) 2020-11-10

Similar Documents

Publication Publication Date Title
ECSP15011603A (es) Subunidades de vacunas de inmersión para peces
CL2019000278A1 (es) Agentes rnai para infección con virus de hepatitis b.
CL2015000487A1 (es) Compuestos derivados de sulfamoilarilamidas; composicion farmaceutica que los comprende, util para la prevencion o tratamiento de una infeccion por el virus de la hepatitis b (vhb).
CL2013001428A1 (es) Compuesto que inhibe la actividad del virus de la hepatitis c (hcv); composición farmacéutica que comprende el compuesto; método de tratamiento de hepatitis c.
CL2016000493A1 (es) Inhibidores de polimerasa hcv.
MX2017006283A (es) Peptidos macrociclicos utiles como inmunomoduladores.
CR20150337A (es) Derivados de pirimidinona y su uso en el tratamiento, mejora o prevencion de una enfermedad viral
MD4589B1 (ro) Compoziţie farmaceutică cu conţinut de sofosbuvir şi utilizarea acesteia în tratamentul hepatitei virale C
CL2013002712A1 (es) Composicion inmunogénica para modular sistema inmune que comprende agentes con patrones asociados a bacterias, virus, hongos y levaduras, protozoos, helmintos y/o priones; uso para tratar enfermedades autoinmunes o infecciosas.
MX2015012576A (es) Composiciones a base de nanoparticulas.
CR20140538A (es) Métodos y composiciones para la modificación de adn objetivo dirigida por arn y para la modificación de la transcripción dirigida por arn
MX2014003308A (es) Vacunas para el virus de la influenza y usos de las mismas.
MX357202B (es) Composicion de particula tipo virus.
MX2016003199A (es) Compuestos de azapiridona y usos de los mismos.
MX2015016627A (es) Vacuna para la malaria.
MX2016007878A (es) Composicion farmaceutica que comprende adalimumab.
CL2014000393A1 (es) Compuestos derivados de benzofurano y sus sales, como inhibidores del virus de hepatitis c; composicion farmaceutica que los comprende; y su uso para el tratamiento o la prevencion de una infeccion por el virus de hepatitis c o de una enfermedad asociada con dicha infeccion.
BR112018012642A2 (pt) vacina de calicivírus felino
CU24580B1 (es) Vectores atenuados de influenza para la prevención y/o tratamiento de enfermedades infecciosas y para el tratamiento de enfermedades oncológicas
BR112013016503A2 (pt) composições e método de vacina de vírus da diarreia viral bovina tipo 1b.
CR20160178A (es) Derivados de desoxinojirimicina y sus métodos de uso
CL2016002879A1 (es) Composiciones farmacéuticas para tratar enfermedades infecciosas
CL2016000300A1 (es) Métodos terapéuticos
MX2016000235A (es) Metodos y composiciones para vacunas del virus del dengue.
BR112015017420A2 (pt) recombinação de vírus influenza